Latest News

Why the new rate hike opposition matters for Consolidated Edison (ED) Officials representing about 9 million New Yorkers are urging regulators to reject Consolidated Edison (ED) rate hikes for 2026 to 2028. They argue that even reduced electricity and gas increases strain households and small businesses. See our latest analysis for Consolidated Edison. Consolidated Edison’s share price has moved to $103.81, with a 1-day share price return of 1.20% and a 7-day share price return of 4.64%,...

Power Corporation of Canada (TSX:POW) is drawing fresh attention after Portage Ventures agreed to manage Point72 Ventures’ fintech portfolio, a US$280 million fund with stakes in 40 relatively mature fintech companies. See our latest analysis for Power Corporation of Canada. Despite a quiet share price over the past month, with the 30 day share price return around flat, the 90 day share price return of 19.01% and a three year total shareholder return of 139.00% suggest momentum has built over...

OneMain Holdings (OMF) moved into focus after JP Morgan cut its rating from Neutral to Underweight. The call was centered on rising credit card and auto delinquencies among non prime borrowers. See our latest analysis for OneMain Holdings. The downgrade came after a sharp 5.1% drop, and that negative reaction is now sitting alongside a 7 day share price return of 7.73% and a 30 day share price return of 3.77% at a last close of US$65.40. Even so, the 90 day share price return of 20.82% and 1...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...

What sparked the latest move in Charter Hall Retail REIT? Charter Hall Retail REIT (ASX:CQR) attracted fresh attention after a Citi report pointed to potential upside in its earnings outlook, coinciding with a move higher in the unit price as investors reacted. See our latest analysis for Charter Hall Retail REIT. At around A$4.14, Charter Hall Retail REIT has posted positive short term momentum, with a 1 month share price return of 2.73% and a 7 day share price return of 1.97%. Its 1 year...

Despite an already strong run, AAA Technologies Limited ( NSE:AAATECH ) shares have been powering on, with a gain of...

If you have been wondering whether Ally Financial's current share price offers real value or just headline appeal, this breakdown is designed to give you a clear, practical view. The stock closed at US$43.61, with returns of 22.0% over 1 year and 54.5% over 3 years, while the last 7 days and year to date show declines of 4.6% and 4.7% respectively. Recent coverage around Ally Financial has focused on its position as a listed diversified financials company, as investors weigh its exposure to...

If you are looking at Microchip Technology and wondering whether the current share price lines up with its underlying worth, you are not alone. The stock last closed at US$74.70, with recent returns of 16.7% over 30 days, 14.9% year to date, and 32.9% over the past year, although the 7 day return was a 0.7% decline. Recent interest around Microchip Technology has focused on how a well known semiconductor name fits into investor portfolios that are increasingly sensitive to price and quality...

FDA Breakthrough Therapy Designation: Why It Matters for Investors The latest move around Revolution Medicines (RVMD) is the FDA granting Breakthrough Therapy Designation to its RAS(ON) G12D inhibitor zoldonrasib for certain previously treated advanced non small cell lung cancer patients. See our latest analysis for Revolution Medicines. The Breakthrough Therapy news arrives after a period of sharp share price swings, with Revolution Medicines now trading at $120.28 and posting a 30 day share...

If you are wondering whether Extreme Networks is priced attractively today, the key question is whether the current US$15.96 share price still lines up with what the business is actually worth. The stock has risen 2.2% over the last 7 days, although returns over 30 days, year to date and the past year sit at 4.1%, 3.5% and 7.9% declines respectively. This may signal changing views on its potential and risks. Recent coverage of Extreme Networks has focused on how investors are reassessing...

Airbnb (ABNB) is back in focus after hiring Ahmad Al-Dahle, a former Meta generative AI leader, as Chief Technology Officer, a move investors are watching closely for its impact on AI powered travel services. See our latest analysis for Airbnb. The appointment of Ahmad Al-Dahle comes as Airbnb’s share price, at US$130.66, reflects mixed momentum, with a 7 day share price return of 6.18% and a 90 day share price return of 3.77%. The 1 year total shareholder return of 3.30% contrasts with a 5...

Key Insights The considerable ownership by individual investors in Astra Microwave Products indicates that they...

Scatec ASA recently signed a Power Purchase Agreement with the Egyptian Electricity Transmission Company for a 1.95 GW solar and 3.9 GWh battery energy storage hybrid project in Egypt, alongside two standalone storage plants, forming Africa’s largest integrated solar and storage installation. This 25-year, US dollar‑denominated, pay‑as‑produced contract for around‑the‑clock baseload power marks the largest investment in Scatec’s history and underlines its push into large‑scale hybrid...

Treasury Wine Estates recently reported weaker trading conditions in key markets such as the US and China, alongside higher costs and a cautious near-term outlook, and announced a company-wide cost-cutting program targeting about A$100 million in annual savings from FY27. At the same time, several small adjustments to its equity incentive plans, including lapses and cancellations of performance and deferred share rights plus a minor share issue, signal tighter alignment between management...

In recent days, LendingClub has emerged as one of the stronger performers among smaller banks after reporting improved quarterly earnings and revenue, drawing investor attention amid weakness in several large U.S. bank stocks. The company’s standing as a high-growth momentum breakout candidate, supported by upbeat analyst estimate revisions and supportive technical trends, has differentiated it from many traditional bank peers. Against this backdrop of stronger short-term earnings momentum,...

If you are wondering whether W.W. Grainger at around US$1,068.72 is priced for strength or stretched, you are not alone. This article is built to help you frame that question clearly. The stock has returned 3.8% over the last 7 days, 4.8% over the last 30 days, 6.5% year to date, but shows a 3.2% decline over the last year, while longer periods such as 3 years and 5 years sit at 96.0% and 187.0% respectively. Recent coverage of W.W. Grainger has centered on its role as a key industrial...

Why Signet Jewelers is on investors’ radar today Signet Jewelers (SIG) has drawn investor attention after recent share price moves, with the stock up 1.7% over the past day, 12.8% over the past week, and 14.3% over the past month. See our latest analysis for Signet Jewelers. The recent 1 month share price return of 14.3%, alongside a year to date share price return of 10.5%, sits against a 1 year total shareholder return of 68.4%. This suggests momentum has been stronger over the longer...

Orla Mining (TSX:OLA) is back in focus after releasing an optimized feasibility study for its South Railroad Gold Project in Nevada and securing board approval to start detailed engineering, procurement, and project execution spending. See our latest analysis for Orla Mining. The South Railroad update comes after a strong run for Orla Mining, with the share price at CA$20.42 and recent momentum reflected in a 90 day share price return of 20.47% and a very large 1 year total shareholder return...

KKR (KKR) shares recently moved after a fresh look at the firm’s fundamentals, with investors weighing its recent returns, revenue and net income figures against the current share price of US$131.42. See our latest analysis for KKR. At the current share price of US$131.42, KKR’s recent 11.75% 90 day share price return contrasts with a 16.12% decline in 1 year total shareholder return. However, 3 year and 5 year total shareholder returns of 152.89% and 241.62% point to stronger longer term...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

If you are trying to figure out whether Unity Software's current share price still makes sense, you are not alone. This article focuses squarely on what you are paying versus what you might be getting. The stock closed at US$40.95 and has seen a 1 year return of 88.1%, even though the last 7 days, 30 days, and year to date show returns of an 8.3% decline, 6.5% decline, and 7.5% decline respectively. Recent attention on Unity has been driven by ongoing interest in its software platform and...

In mid-January 2026, several major brokerages, including BofA Securities, Barclays, Scotiabank, and UBS, updated their views on Americold Realty Trust and the cold storage REIT segment, reshaping investor expectations for the business. The mix of cautious sector commentary alongside recognition of Americold’s expanding global temperature-controlled warehousing footprint offers a more nuanced picture of its longer-term prospects. We’ll now examine how this cluster of analyst revisions,...

Algonquin Power & Utilities (TSX:AQN) has drawn fresh attention after appointing Peter Norgeot as Chief Operating Officer. The move is tied to its ongoing effort to refocus on regulated utilities and tighten capital execution. See our latest analysis for Algonquin Power & Utilities. The appointment of a new COO comes as Algonquin’s CA$9.00 share price has recorded a 7.1% 1 month share price return and a 7.5% 3 month share price return. The 1 year total shareholder return of 47.8% follows a...

BioCryst Pharmaceuticals (BCRX) recently issued full year 2026 earnings guidance, telling investors it expects total revenue between US$635 million and US$660 million, a data point that now anchors many discussions around the stock. See our latest analysis for BioCryst Pharmaceuticals. Even with the fresh 2026 revenue guidance and a slot at the J.P. Morgan Healthcare Conference, BioCryst Pharmaceuticals’ recent trading has been weak, with a 1 day share price return of 7.11% and a 7 day share...